HOME › DRUGS › RIVASTIGMINE
ACTIVE SUBSTANCE / INN

RIVASTIGMINE

Brand name(s): Rivastigmine 1 A Pharma, Rivastigmine Sandoz, Rivastigmine 3M Health Care Ltd, EXELON, Exelon, Rivastigmine Teva, Nimvastid, RIVASTIGMINE, Rivastigmine Actavis, Prometax, Rivastigmine Hexal
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
DISCONTINUED
Alzheimer Disease;Dementia;Parkinson Disease
Dementia;Alzheimer Disease;Parkinson Disease
ACTIVE SUBSTANCE
Rivastigmine
REGULATORS
FDA · EMA
SPONSORS / MAH
SANDOZ, 1 A Pharma GmbH, Sandoz GmbH
TOTAL APPLICATIONS
12
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RIVASTIGMINEANDA207308AMNEAL PHARMSPrescription
RIVASTIGMINEANDA204403ALVOGENDiscontinued
EXELONNDA022083SANDOZPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ExelonNovartis Europharm LimitedAuthorised11/05/1998Dementia;Alzheimer Disease;Parkinson Disease
Rivastigmine 1 A Pharma1 A Pharma GmbHAuthorised11/12/2009Alzheimer Disease;Dementia;Parkinson Disease
Rivastigmine HexalHexal AG Authorised11/12/2009Dementia;Alzheimer Disease;Parkinson Disease
Rivastigmine SandozSandoz GmbHAuthorised10/12/2009Dementia;Alzheimer Disease;Parkinson Disease
NimvastidKrka, d.d., Novo mestoAuthorised11/05/2009Dementia;Alzheimer Disease;Parkinson Disease
Rivastigmine ActavisActavis Group PTC ehfAuthorised16/06/2011Dementia;Alzheimer Disease;Parkinson Disease
PrometaxAlmirall, S.A.Authorised04/12/1998Alzheimer Disease;Parkinson Disease;Dementia
Rivastigmine 3M Health Care Ltd3M Health Care LimitedWithdrawn03/04/2014Alzheimer Disease
Rivastigmine TevaTeva Pharma B.V.Withdrawn17/04/2009Dementia;Alzheimer Disease;Parkinson Disease

FULL INTELLIGENCE ON RIVASTIGMINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →